Interactions Between Cyclosporin and Lipid-Lowering Drugs

@article{sberg2012InteractionsBC,
  title={Interactions Between Cyclosporin and Lipid-Lowering Drugs},
  author={Anders {\AA}sberg},
  journal={Drugs},
  year={2012},
  volume={63},
  pages={367-378}
}
  • Anders Åsberg
  • Published 2012
  • Medicine
  • Drugs
  • Dyslipidaemia is more frequent in solid organ transplant recipients than in the general population, primarily as a result of immunosuppressive drug treatment. Both cyclosporin and corticosteroids are associated with dyslipidaemic adverse effects. In order to reduce the overall cardiovascular risk in these patients, lipid-lowering drugs have become widely used, especially HMG-CoA reductase inhibitors (statins). Cyclosporin, as well as most statins (lovastatin, simvastatin, atorvastatin and… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 52 CITATIONS, ESTIMATED 50% COVERAGE

    Cytochrome P450-mediated cardiovascular drug interactions

    • André Scheen
    • Medicine
    • Expert opinion on drug metabolism & toxicology
    • 2011
    VIEW 2 EXCERPTS
    CITES BACKGROUND & RESULTS

    The pros and the cons of mTOR inhibitors in kidney transplantation

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2004
    2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 71 REFERENCES

    Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.

    VIEW 4 EXCERPTS
    HIGHLY INFLUENTIAL

    The interaction of fluvastatin and cyclosporin A in renal transplant patients.

    VIEW 1 EXCERPT

    Pharmacokinetics and Pharmacodynamics of Fluvastatin in Heart Transplant Recipients Taking Cyclosporine A

    VIEW 1 EXCERPT

    Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients.

    • L Renders, I Mayer-Kadner, +5 authors Ingeborg A. Hauser
    • Medicine
    • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
    • 2001
    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL

    Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients.

    VIEW 4 EXCERPTS
    HIGHLY INFLUENTIAL

    Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation.

    VIEW 2 EXCERPTS
    HIGHLY INFLUENTIAL

    Clinical Pharmacokinetics of Fluvastatin

    VIEW 2 EXCERPTS